Metabolic effects of GLP-1 receptor agonists in rheumatology patients and inflammatory outcomes: a single-centre retrospective cohort

More on GLP-1 and incretin signalling

• Six blood metabolites distinguish metabolic health in obesity

  Frontiers in Endocrinology · 4 Oct 2026

• Retatrutide reduces bodyweight in obesity and type 2 diabetes

  Lancet · 4 Oct 2026

• Survodutide reduces weight in adults with diabetes and obesity

  The New England Journal of Medicine · 4 Oct 2026

• Lipid accumulation index linked to cardiometabolic multimorbidity

  The Journal of the Egyptian Public Health Association · 5 Oct 2026